<DOC>
	<DOCNO>NCT01896323</DOCNO>
	<brief_summary>This single-center open-label study compare CC-223 ( study drug investigate ) interact drug ketoconazole .</brief_summary>
	<brief_title>CC-223 Ketoconazole Drug-Drug Interaction Study</brief_title>
	<detailed_description>This 2 period study , last 6 week long . About 14 male enter study , receive study drug ( single dose 20 mg CC-223 ) 400 mg ketoconazole .</detailed_description>
	<mesh_term>Ketoconazole</mesh_term>
	<criteria>1 . Must understand voluntarily sign write informed consent form participation . 2 . Must able communicate study doctor , understand comply requirement study , agree adhere restriction examination schedule . 3 . Healthy male subject race 18 65 year age , good health determine physical examination . For male : Agree use barrier contraception make natural ( animal ) membrane ( example , latex polyurethane condom acceptable ) engage sexual activity female childbearing potential study medication , least 28 day last dose study medication . 4 . Must body mass index 18 33 kilograms/meter square . 5 . Clinical laboratory test must within normal limit acceptable study doctor . 6 . Must fever , blood pressure 90/50 140/90 millimeter mercury , pulse rate : 40 110 beat per minute . 7 . Must normal clinically acceptable 12lead electrocardiogram . 1 . History clinically significant relevant neurological , gastrointestinal , renal , hepatic , cardiovascular , psychological , pulmonary , metabolic , endocrine , hematological , allergic disease , drug allergy , major disorder . 2 . Any condition place subject unacceptable risk participate study , confound ability interpret data study . 3 . Used prescribed topical medication within one month first dose study drug , unless consultation sponsor study doctor . 4 . Used nonprescribed systemic topical medication ( include vitamin/mineral supplement , herbal medicine ) within 2 week ( 30 day St. John 's WortÂ® ) first dose administration , unless sponsor agreement obtain . 5 . Has surgical medical condition possibly affect drug absorption , distribution , metabolism excretion study drug , example , bariatric procedure . 6 . Donated blood plasma within 2 month first dose study drug . 7 . History drug abuse within 2 year dose , positive drug screen test reflect consumption illicit drug . 8 . History alcohol abuse within 2 year dose , positive alcohol screen . 9 . Known serum hepatitis know carrier hepatitis B surface antigen , hepatitis C antibody , positive result test Human Immune virus antibody Screening . 10 . Exposed investigational drug within one month 30 day first dose study drug . 11 . Smoke 10 cigarette per day , equivalent tobacco product .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>